Compare Charles River Laboratories Intl. Inc (CRL) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs United States Oil ETF — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while United States Oil ETF trades at $148.2 (market cap $1.90B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 7.5× United States Oil ETF's market cap, and United States Oil ETF is more actively traded (5,932,922 versus 1,176,885). Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and United States Oil ETF for 21 Days on average.
| CRL | USO | |
|---|---|---|
Market Cap | $14.23B | $1.90B |
Volume | 1,176,885 | 5,932,922 |
Sector | Health | — |
52-Week High | $310.77 | $161.86 |
52-Week Low | $149.93 | $66.17 |
Typical Hold Time | 33 Days | 21 Days |
Enterprise Value | $17.06B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $298.00, down 0.77% on the day, with a bullish technical signal supported by moving averages. The company has beaten earnings estimates for three consecutive quarters, though it reported a net loss of -$144.34M for 2025. Analyst consensus is strongly positive with a $305.50 price target, and recent news highlights a strategic growth plan targeting 5%-7% revenue growth by 2030.
The stock's outlook is supported by strong analyst buy ratings and a clear growth strategy, but faces risks from negative profitability metrics and high valuation multiples. Investment opportunity hinges on successful execution of margin expansion and cost savings initiatives, while key risks include persistent net losses and competitive pressures in the healthcare services sector.
USO is trading at $147.58, up 2.55% with a bullish technical signal supported by moving averages. Recent news highlights mixed oil price movements amid Middle East tensions and OPEC+ maintaining steady output. The stock shows strength above key support levels with neutral oscillators suggesting balanced momentum.
The outlook remains cautiously optimistic given geopolitical risks and supply dynamics. Key opportunities include potential price support from production disruptions, while risks involve volatility from geopolitical events and coordinated reserve releases pressuring prices.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
